Wall Street’s Top Analysts Upgrades, Downgrades & Initiations
$LLY, $ECYT, $ESV, $NFLX, $PG
Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Street’s Top analysts outlook for Key issues for Monday, as follows:
Eli Lilly (NYSE:LLY) was raised to Market Perform from Underperform at BMO Capital Markets.
Endocyte Inc. (NASDAQ:ECYT) was started as Buy with a 17 price target at Jefferies. Shares were last seen at 10.54.
Ensco PLC (NYSE:ESV) was raised to Outperform from Neutral at Credit Suisse.
Netflix Inc. (NASDAQ:NFLX) was raised to Buy from Hold by Deutsche Bank, following multiple analyst target price hikes this week.
Procter & Gamble Co. (NYSE:PG) was maintained as Buy at Merrill Lynch, but the price target was cut to 90 from 100 during the call.
Have a terrific week.
The following two tabs change content below.
Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.